Elevance Health Total Assets Growth & History (ELV)
Elevance Health's total assets was $121.49B for fiscal 2025.
View full Elevance Health company overviewElevance Health annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $121.49B | $4.61B | +3.94% |
| 2024 | 2024-12-31 | $116.89B | $7.96B | +7.31% |
| 2023 | 2023-12-31 | $108.93B | $6.17B | +6.01% |
| 2022 | 2022-12-31 | $102.75B | $5.29B | +5.43% |
| 2021 | 2021-12-31 | $97.46B | $10.85B | +12.52% |
| 2020 | 2020-12-31 | $86.61B | $9.16B | +11.83% |
| 2019 | 2019-12-31 | $77.45B | $5.88B | +8.22% |
| 2018 | 2018-12-31 | $71.57B | $1.03B | +1.46% |
| 2017 | 2017-12-31 | $70.54B | $5.46B | +8.38% |
| 2016 | 2016-12-31 | $65.08B | $3.37B | +5.45% |
| 2015 | 2015-12-31 | $61.72B | $41.5M | +0.07% |
| 2014 | 2014-12-31 | $61.68B | $2.10B | +3.53% |
| 2013 | 2013-12-31 | $59.57B | $619.1M | +1.05% |
| 2012 | 2012-12-31 | $58.96B | $6.79B | +13.02% |
| 2011 | 2011-12-31 | $52.16B | $2.00B | +3.98% |
| 2010 | 2010-12-31 | $50.17B | −$1.96B | −3.76% |
| 2009 | 2009-12-31 | $52.13B | $3.72B | +7.69% |
| 2008 | 2008-12-31 | $48.40B | — | — |
Elevance Health quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $126.44B | $4.50B | +3.69% |
| Q1 2026 | 2026-03-31 | $125.83B | $6.11B | +5.10% |
| Q4 2025 | 2025-12-31 | $121.49B | $4.61B | +3.94% |
| Q3 2025 | 2025-09-30 | $122.75B | $6.22B | +5.33% |
| Q2 2025 | 2025-06-30 | $121.94B | $8.95B | +7.92% |
| Q1 2025 | 2025-03-31 | $119.72B | $7.82B | +6.99% |
| Q4 2024 | 2024-12-31 | $116.89B | $7.96B | +7.31% |
| Q3 2024 | 2024-09-30 | $116.53B | $6.05B | +5.48% |
| Q2 2024 | 2024-06-30 | $112.99B | $3.82B | +3.50% |
| Q1 2024 | 2024-03-31 | $111.89B | $2.85B | +2.62% |
| Q4 2023 | 2023-12-31 | $108.93B | $6.17B | +6.01% |
| Q3 2023 | 2023-09-30 | $110.48B | $7.45B | +7.23% |
| Q2 2023 | 2023-06-30 | $109.17B | $8.29B | +8.22% |
| Q1 2023 | 2023-03-31 | $109.04B | $8.55B | +8.51% |
| Q4 2022 | 2022-12-31 | $102.75B | $5.29B | +5.43% |
| Q3 2022 | 2022-09-30 | $103.03B | $4.97B | +5.06% |
| Q2 2022 | 2022-06-30 | $100.88B | $4.78B | +4.97% |
| Q1 2022 | 2022-03-31 | $100.49B | $4.80B | +5.02% |
| Q4 2021 | 2021-12-31 | $97.46B | $10.85B | +12.52% |
| Q3 2021 | 2021-09-30 | $98.06B | $11.49B | +13.27% |
| Q2 2021 | 2021-06-30 | $96.10B | $8.12B | +9.23% |
| Q1 2021 | 2021-03-31 | $95.68B | $13.28B | +16.12% |
| Q4 2020 | 2020-12-31 | $86.61B | $9.16B | +11.83% |
| Q3 2020 | 2020-09-30 | $86.57B | $8.77B | +11.26% |
| Q2 2020 | 2020-06-30 | $87.98B | $12.13B | +15.99% |
| Q1 2020 | 2020-03-31 | $82.40B | $7.88B | +10.57% |
| Q4 2019 | 2019-12-31 | $77.45B | $5.88B | +8.22% |
| Q3 2019 | 2019-09-30 | $77.81B | $3.36B | +4.52% |
| Q2 2019 | 2019-06-30 | $75.85B | $1.48B | +1.99% |
| Q1 2019 | 2019-03-31 | $74.52B | $1.22B | +1.67% |
| Q4 2018 | 2018-12-31 | $71.57B | $1.03B | +1.46% |
| Q3 2018 | 2018-09-30 | $74.44B | $6.14B | +8.98% |
| Q2 2018 | 2018-06-30 | $74.37B | $6.13B | +8.98% |
| Q1 2018 | 2018-03-31 | $73.30B | $4.36B | +6.32% |
| Q4 2017 | 2017-12-31 | $70.54B | $5.46B | +8.38% |
| Q3 2017 | 2017-09-30 | $68.31B | $3.91B | +6.07% |
| Q2 2017 | 2017-06-30 | $68.24B | $4.17B | +6.52% |
| Q1 2017 | 2017-03-31 | $68.94B | $5.08B | +7.96% |
| Q4 2016 | 2016-12-31 | $65.08B | $3.37B | +5.45% |
| Q3 2016 | 2016-09-30 | $64.40B | $2.06B | +3.31% |
| Q2 2016 | 2016-06-30 | $64.06B | −$201.2M | −0.31% |
| Q1 2016 | 2016-03-31 | $63.86B | −$1.69B | −2.57% |
| Q4 2015 | 2015-12-31 | $61.72B | $41.5M | +0.07% |
| Q3 2015 | 2015-09-30 | $62.34B | $277.4M | +0.45% |
| Q2 2015 | 2015-06-30 | $64.26B | $1.96B | +3.15% |
| Q1 2015 | 2015-03-31 | $65.55B | $3.86B | +6.26% |
| Q4 2014 | 2014-12-31 | $61.68B | $2.10B | +3.53% |
| Q3 2014 | 2014-09-30 | $62.06B | — | — |
| Q2 2014 | 2014-06-30 | $62.30B | — | — |
| Q1 2014 | 2014-03-31 | $61.69B | $2.28B | +3.83% |
| Q4 2013 | 2013-12-31 | $59.57B | $619.1M | +1.05% |
| Q1 2013 | 2013-03-31 | $59.41B | $6.91B | +13.17% |
| Q4 2012 | 2012-12-31 | $58.96B | $6.79B | +13.02% |
| Q3 2012 | 2012-09-30 | $55.82B | — | — |
| Q2 2012 | 2012-06-30 | $54.53B | — | — |
| Q1 2012 | 2012-03-31 | $52.50B | $1.58B | +3.10% |
| Q4 2011 | 2011-12-31 | $52.16B | $2.00B | +3.98% |
| Q1 2011 | 2011-03-31 | $50.92B | −$262.9M | −0.51% |
| Q4 2010 | 2010-12-31 | $50.17B | −$1.96B | −3.76% |
| Q3 2010 | 2010-09-30 | $51.03B | $1.53B | +3.10% |
| Q2 2010 | 2010-06-30 | $50.16B | $815.7M | +1.65% |
| Q1 2010 | 2010-03-31 | $51.18B | — | — |
| Q4 2009 | 2009-12-31 | $52.13B | $3.72B | +7.69% |
| Q3 2009 | 2009-09-30 | $49.50B | — | — |
| Q2 2009 | 2009-06-30 | $49.34B | — | — |
| Q4 2008 | 2008-12-31 | $48.40B | — | — |
Elevance Health total assets trends
Over the last five fiscal years, Elevance Health's total assets increased from $86.61B to $121.49B, a change of $34.88B. The latest reported quarter, Q2 2026, shows $126.44B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Elevance Health source filings ↗